Your browser doesn't support javascript.
loading
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol).
Hickman, Matthew; Dillon, John F; Elliott, Lawrie; De Angelis, Daniela; Vickerman, Peter; Foster, Graham; Donnan, Peter; Eriksen, Ann; Flowers, Paul; Goldberg, David; Hollingworth, William; Ijaz, Samreen; Liddell, David; Mandal, Sema; Martin, Natasha; Beer, Lewis J Z; Drysdale, Kate; Fraser, Hannah; Glass, Rachel; Graham, Lesley; Gunson, Rory N; Hamilton, Emma; Harris, Helen; Harris, Magdalena; Harris, Ross; Heinsbroek, Ellen; Hope, Vivian; Horwood, Jeremy; Inglis, Sarah Karen; Innes, Hamish; Lane, Athene; Meadows, Jade; McAuley, Andrew; Metcalfe, Chris; Migchelsen, Stephanie; Murray, Alex; Myring, Gareth; Palmateer, Norah E; Presanis, Anne; Radley, Andrew; Ramsay, Mary; Samartsidis, Pantelis; Simmons, Ruth; Sinka, Katy; Vojt, Gabriele; Ward, Zoe; Whiteley, David; Yeung, Alan; Hutchinson, Sharon J.
Afiliação
  • Hickman M; Population Health Sciences, Bristol Medical School, Bristol, Bristol, UK matthew.hickman@bristol.ac.uk.
  • Dillon JF; Hepatology & Gastroenterology, Clinical & Molecular Medicine, School of Medicine, University of Dundee, Dundee, UK.
  • Elliott L; Glasgow Caledonian University, Glasgow, UK.
  • De Angelis D; MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Vickerman P; Population Health Sciences, Bristol Medical School, Bristol, Bristol, UK.
  • Foster G; Blizard Institute, Queen Mary University of London, London, UK.
  • Donnan P; Barts Health NHS Trust, London, UK.
  • Eriksen A; Dundee Epidemiology and Biostatistics Unit, University of Dundee, Dundee, UK.
  • Flowers P; Tayside Health Board, Dundee, UK.
  • Goldberg D; Glasgow Caledonian University, Glasgow, UK.
  • Hollingworth W; Glasgow Caledonian University, Glasgow, UK.
  • Ijaz S; Health Protection Scotland, Glasgow, UK.
  • Liddell D; Population Health Sciences, Bristol Medical School, Bristol, Bristol, UK.
  • Mandal S; National Infection Service, Public Health England, London, UK.
  • Martin N; Scottish Drugs Forum, Edinburgh, UK.
  • Beer LJZ; National Infection Service, Public Health England, London, UK.
  • Drysdale K; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, UK.
  • Fraser H; Tayside Clinical Trials Unit, Tayside Medical Science Centre, University of Dundee, Dundee, UK.
  • Glass R; Blizard Institute, Queen Mary University of London, London, UK.
  • Graham L; Barts Health NHS Trust, London, UK.
  • Gunson RN; Population Health Sciences, Bristol Medical School, Bristol, Bristol, UK.
  • Hamilton E; National Infection Service, Public Health England, London, UK.
  • Harris H; ISD Scotland, Edinburgh, UK.
  • Harris M; West Of Scotland Specialist Virology Centre, NHS Greater Glasgow & Clyde Board, Glasgow, UK.
  • Harris R; Scottish Drug Forum, Edinburgh, UK.
  • Heinsbroek E; National Infection Service, Public Health England, London, UK.
  • Hope V; London School of Hygiene and Tropical Medicine, London, UK.
  • Horwood J; National Infection Service, Public Health England, London, UK.
  • Inglis SK; National Infection Service, Public Health England, London, UK.
  • Innes H; Liverpool John Moores University, Liverpool, UK.
  • Lane A; Population Health Sciences, Bristol Medical School, Bristol, Bristol, UK.
  • Meadows J; Tayside Clinical Trials Unit, Tayside Medical Science Centre, University of Dundee, Dundee, UK.
  • McAuley A; Glasgow Caledonian University, Glasgow, UK.
  • Metcalfe C; Health Protection Scotland, Glasgow, UK.
  • Migchelsen S; Population Health Sciences, Bristol Medical School, Bristol, Bristol, UK.
  • Murray A; Population Health Sciences, Bristol Medical School, Bristol, Bristol, UK.
  • Myring G; Glasgow Caledonian University, Glasgow, UK.
  • Palmateer NE; Health Protection Scotland, Glasgow, UK.
  • Presanis A; Population Health Sciences, Bristol Medical School, Bristol, Bristol, UK.
  • Radley A; National Infection Service, Public Health England, London, UK.
  • Ramsay M; Scottish Drug Forum, Edinburgh, UK.
  • Samartsidis P; Population Health Sciences, Bristol Medical School, Bristol, Bristol, UK.
  • Simmons R; Glasgow Caledonian University, Glasgow, UK.
  • Sinka K; Health Protection Scotland, Glasgow, UK.
  • Vojt G; MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Ward Z; Hepatology & Gastroenterology, Clinical & Molecular Medicine, School of Medicine, University of Dundee, Dundee, UK.
  • Whiteley D; Directorate of Public Health, NHS Tayside, Dundee, UK.
  • Yeung A; National Infection Service, Public Health England, London, UK.
  • Hutchinson SJ; MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
BMJ Open ; 9(9): e029538, 2019 09 24.
Article em En | MEDLINE | ID: mdl-31551376

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Abuso de Substâncias por Via Intravenosa / Controle de Doenças Transmissíveis / Hepacivirus / Hepatite C Crônica / Redução do Dano Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: BMJ Open Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Abuso de Substâncias por Via Intravenosa / Controle de Doenças Transmissíveis / Hepacivirus / Hepatite C Crônica / Redução do Dano Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: BMJ Open Ano de publicação: 2019 Tipo de documento: Article